You are here

Article info

Article menu
Pathophysiology/complications
Effect of lactate administration on cerebral blood flow during hypoglycemia in people with type 1 diabetes

Authors

  • Lian A van Meijel Department of Internal Medicine, Radboudumc, Nijmegen, The NetherlandsDepartment of Internal Medicine, Maxima Medical Centre, Veldhoven, The Netherlands PubMed articlesGoogle scholar articles
  • Jack J A van Asten Department of Medical Imaging/Radiology, Radboudumc, Nijmegen, The Netherlands PubMed articlesGoogle scholar articles
  • Joanes Grandjean Department of Medical Imaging/Radiology, Radboudumc, Nijmegen, The NetherlandsDepartment of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Centre for Neuroscience, Radboudumc, Nijmegen, The Netherlands PubMed articlesGoogle scholar articles
  • Arend Heerschap Department of Medical Imaging/Radiology, Radboudumc, Nijmegen, The Netherlands PubMed articlesGoogle scholar articles
  • Cornelis J Tack Department of Internal Medicine, Radboudumc, Nijmegen, The Netherlands PubMed articlesGoogle scholar articles
  • Marinette van der Graaf Department of Medical Imaging/Radiology, Radboudumc, Nijmegen, The NetherlandsDepartment of Pediatrics, Radboudumc, Nijmegen, The Netherlands PubMed articlesGoogle scholar articles
  • Evita C Wiegers Department of Medical Imaging/Radiology, Radboudumc, Nijmegen, The NetherlandsHigh Field MR Research Group, Department of Radiology, University Medical Center Utrecht Imaging Division, Utrecht, The Netherlands PubMed articlesGoogle scholar articles
  • Bastiaan E de Galan Department of Internal Medicine, Radboudumc, Nijmegen, The NetherlandsDepartment of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Bastiaan E de Galan; bastiaan.degalan{at}radboudumc.nl
View Full Text

Citation

van Meijel LA, van Asten JJA, Grandjean J, et al
Effect of lactate administration on cerebral blood flow during hypoglycemia in people with type 1 diabetes
BMJ Open Diabetes Research and Care 2022;10:e002401. doi: 10.1136/bmjdrc-2021-002401

Publication history

  • Received June 6, 2021
  • Accepted February 22, 2022
  • First published March 23, 2022.
Online issue publication 
April 30, 2022

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.